Treatment of 41 Cases of AIDS with Antiretrovirals

YANG Rong-rong,GUI Xi-en,ZHANG Yong-xi,FU Xue-dong

DOI: https://doi.org/10.3870/j.issn.1004-0781.2006.10.020

2006-01-01

Abstract:Objective To survey the therapeutic effectiveness of two nucleoside-inhibitors plus one non-nucleoside-inhibitor of reverse transcriptase in the treatment of patients with acquired immuro deficiency syndrome(AIDS). Methods 41 patients with AIDS were subjected to the medication carried out strictly according to the directions.The course of treatment lasted 21.2 months in adults and 16.6 months in children.The patients were followed up at regular intervals.Improvement in symptoms was kept under observation.CD_4~+ lymphocyte counts and viral load(VL) were measured.Adverse drug reactions were closely monitored and corresponding measures were taken if any of these reactions were encountered.For those patients with unsatisfactory curative effects,drug resistance analyses at the genome level were carried out. Results During the course of treatment,none of the patients died.The incidence of opportunistic infections dropped from 56.1% before the treatment to 9.8% after the treatment.The viral load was decreased to below the detection level along with the increase in the counts and percentages of CD_4~+ lymphocytes.In 4 patients the CD_4~+ counts were shown to decrease again after an increase in a period of time and the viral load rose to levels above the detection limit.In the mean time they suffered opportunistic infections.Besides,the HIV in 2 patients was demonstrated to have acquired drug resistance as revealed by the drug resistance analysis at the genome level.The adverse reactions encountered were: 4 cases of skin rash from mild to moderate degree,2 cases of generalized eruption,9 cases of peripheral neuritis,7 cases of abnormal liver function and 1 case of severe anemia that responded well to the treatment with recombinant human erythropoietin(rHuEPO). Conclusion The antivirals provided free of charge by the State was shown to be fairly effective in the treatment of patients with AIDS.The treatment plan should be timely readjusted in patients manifesting severe adverse reactions.Patients with not very severe adverse reactions should be encouraged to insist on further treatment associated with symptomatic managements.The prophylaxis and treatment of AIDS have to face new challenges owing to the appearance of drug resistant HIV variants.